AstraZeneca PLC - Preferred Stock and Other Adjustments
AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Preferred-Stock-and-Other-Adjustments" stands at -53.38 Million United States Dollars for the trailing twelve months (TTM) period ending 06/30/2024, the lowest value since 03/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -52.11 Million United States Dollars compared to the value the year prior.
The 1 year change is -52.11 Million United States Dollars.
The 3 year change is -79.85 Million United States Dollars.
The 5 year change is -41.44 Million United States Dollars.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2022, to it's latest available value, on 06/30/2024, is +63.62 Million.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2021, to it's latest available value, on 06/30/2024, is -112.75 Million.
Preferred Stock and Other Adjustments for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Preferred Stock and Other Adjustments | 905,699,262,464.00 |
 | Johnson & Johnson - Preferred Stock and Other Adjustments | 486,508,953,600.00 |
 | AbbVie Inc - Preferred Stock and Other Adjustments | 399,570,305,024.00 |
 | Roche Holding AG - Preferred Stock and Other Adjustments | 317,433,206,677.55 |
 | Novartis AG - Preferred Stock and Other Adjustments | 255,096,620,580.91 |